Background: The authors hypothesized a difference in plasma-effect site equilibration, depicted by a first-order constant k(e0), depending on the injection rate of propofol.
Methods: Sixty-one patients received 2.5 mg/kg propofol given as a bolus or as a 1-, 2-, or 3-min infusion. The Bispectral Index was used to monitor drug effect. Propofol predicted plasma concentration was calculated using a three-compartment model and the effect site concentration over time as the convolution between the predicted plasma concentration and the disposition function of the effect site concentration. The authors evaluated the influence of the infusion rate on the k(e0) by comparing the model with one k(e0) for all groups with models estimating different k(e0) values for each group. The authors also assessed the accuracy of two pharmacokinetic models after bolus injection.
Results: The best model based was a fixed (Bispectral Index > or = 90) plus sigmoidal model (Bispectral Index < 90) with two values of k(e0), one for the bolus (t(1/2) k(e0) = 1.2 min) and one for the infusions (t(1/2) k(e0) = 2.2 min). However, the tested pharmacokinetic models poorly predicted the arterial concentrations in the first minutes after bolus injection. Simulations showed the requirement for two k(e0) values for bolus and infusion was mostly a compensation for the inaccurate prediction of arterial concentrations after a bolus.
Conclusion: Propofol plasma-effect site equilibration occurs more rapidly after a bolus than after rapid infusion, based on the electroencephalogram as a drug effect measure, mostly because of misspecification of the pharmacokinetic model in the first minutes after bolus.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.anes.0000278902.15505.f8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessment of the antinociceptive effect of a single fentanyl bolus dose in children: A pharmacokinetic and pharmacodynamic analysis based on the nociception level index during sevoflurane general anesthesia.
Paediatr Anaesth
December 2024
División de Anestesiología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Article Synopsis
- The Nociception Level Index is a tool that helps doctors understand pain balance in kids, but it hasn't been tested much before.
- The study looked at how well the Nociception Level Index works to track pain and the effect of fentanyl (a pain medicine) in kids getting certain surgeries.
- Nineteen children were tested, and results showed that fentanyl helped lower pain levels after it was given, but pain signs returned to higher levels after a while.
Understanding time to peak effect of propofol as sole agent on bispectral index in children aged 2-12 years.
Paediatr Anaesth
October 2024
Department of Pediatric Anesthesia, University Children's Hospital Basel UKBB, Basel, Switzerland.
Background: The pharmacodynamics of propofol in children have previously been described with the proprietary bispectral index (BIS) as an effect-site marker, and it has been suggested that the rate of onset of propofol might be age dependent, that is, a shorter time to peak effect in younger children. However, these analyses were potentially confounded by co-administered drugs, in particular opioids and benzodiazepines. Thus, the goal of this prospective study was to characterize the influence of age and weight on the onset of hypnotic effects from propofol, reflected by the time to peak of propofol effect-site concentration in the absence of additional drugs.
View Article and Find Full Text PDFDabigatran pharmacokinetic-pharmacodynamic in sheep: Informing dose for anticoagulation during cardiopulmonary bypass.
Perfusion
January 2024
Department Anesthesiology, University of Auckland, Auckland, New Zealand.
Background: The effect of the anticoagulant, dabigatran, and its antagonist, idarucizumab, on coagulation remains poorly quantified. There are few pharmacokinetic-pharmacodynamic data available to determine dabigatran dose in humans or animals undergoing cardiopulmonary bypass.
Methods: Five sheep were given intravenous dabigatran 4 mg/kg.
How obesity affects the disposition of intravenous anesthetics.
Curr Opin Anaesthesiol
August 2023
Department of Anesthesiology, Fukushima Medical University, 1 Hikarigaoka, Fukushima, Fukushima, Japan.
Article Synopsis
- The review emphasizes the importance of understanding how obesity affects the disposition of intravenous anesthetics to ensure proper dosing and prevent issues like intraoperative awareness and delayed recovery.
- Recently developed 'second generation' pharmacokinetic models for drugs like propofol, remifentanil, and remimazolam include factors such as body weight and age, improving their predictive accuracy for obese patients.
- Utilizing these advanced pharmacokinetic models in simulations or target-controlled infusion (TCI) is crucial for predicting drug concentrations and effects in patients with varying degrees of obesity, especially severe cases.
Rocuronium pharmacokinetics and pharmacodynamics in the adductor pollicis and masseter muscles.
Acta Anaesthesiol Scand
July 2016
Departamento de Anestesiología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Marcoleta 367, PO Box: 114-D, Santiago, Chile.
Background: The aim of this study was to characterize the dose-effect relationship of rocuronium at the adductor pollicis and masseter muscles.
Methods: Ten, ASA I, adult patients, received a bolus dose of rocuronium 0.3 mg/kg during propofol based anesthesia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!